# Study Title: A Multicenter, Prospective, Modified Platform Trial Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Matched Standard of Care Controls in the Management of Nonhealing Pressure Ulcers.

> clinical trial · VERIFIED · 2026-06-24

Status: RECRUITING · Sponsor: Sequence LifeScience, Inc. · Condition: Skin Ulcer

- Company: Sequence LifeScience, Inc.
- Sector: regenerative-medicine
- Primary source: https://clinicaltrials.gov/study/NCT07665268

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.